Teva Pharma (TEVA) Announces US Approval of a Generic Version of Forteo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. IBM
9. CRWV
10. SKYD

Go back to Teva Pharma (TEVA) Announces US Approval of a Generic Version of Forteo

Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.

November 17, 2023 8:30 AM EST

Forteo® (teriparatide injection) is indicated to treat osteoporosis among certain women and men. This approval showcases Tevas proven strengths in complex generic formulations development and device engineering. The approval and subsequent launch will enhance access to a critical treatment option for patients while serving to demonstrate Tevas strategic goal of sustaining a generic powerhouse.

PARSIPPANY, N.J. & TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced... More